Endocrine Conditions and COVID-19

Horm Metab Res. 2020 Jul;52(7):471-484. doi: 10.1055/a-1172-1352. Epub 2020 Jun 8.

Abstract

COVID-19 was declared a global pandemic by the WHO and has affected millions of patients around the world. COVID-19 disproportionately affects persons with endocrine conditions, thus putting them at an increased risk for severe disease. We discuss the mechanisms that place persons with endocrine conditions at an additional risk for severe COVID-19 and review the evidence. We also suggest precautions and management of endocrine conditions in the setting of global curfews being imposed and offer practical tips for uninterrupted endocrine care.

Publication types

  • Review

MeSH terms

  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy
  • Endocrine System Diseases / complications*
  • Endocrine System Diseases / epidemiology
  • Endocrine System Diseases / therapy
  • Humans
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy

Grants and funding

Funding Information This work was funded by the intramural research program of the National Institutes of Health.